Partnered Discovery

MorphoSys has research and development agreements with a number of leading pharmaceutical and biotechnology companies. Upfront payments at signature, annual license payments in exchange for access to MorphoSys’s technologies, development-dependent milestone payments and royalties on product sales are standard components of these agreements.

 

View Full Pipeline

MorphoSys’s portfolio comprises more than 90 antibody development programs.